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Abstract
Background: During murine hypothalamic development, different neuroendocrine cell phenotypes are generated
in overlapping periods; this suggests that cell-type specific developmental programs operate to achieve complete
maturation. A balance between programs that include cell proliferation, cell cycle withdrawal as well as epigenetic
regulation of gene expression characterizes neurogenesis. Thyrotropin releasing hormone (TRH) is a peptide that
regulates energy homeostasis and autonomic responses. To better understand the molecular mechanisms
underlying TRH neuron development, we performed a genome wide study of its transcriptome during fetal
hypothalamic development.
Results: In primary cultures, TRH cells constitute 2% of the total fetal hypothalamic cell population. To purify these
cells, we took advantage of the fact that the segment spanning -774 to +84 bp of the Trh gene regulatory region
confers specific expression of the green fluorescent protein (GFP) in the TRH cells. Transfected TRH cells were
purified by fluorescence activated cell sorting, various cell preparations pooled, and their transcriptome compared
to that of GFP- hypothalamic cells. TRH cells undergoing the terminal phase of differentiation, expressed genes
implicated in protein biosynthesis, intracellular signaling and transcriptional control. Among the transcription-
associated transcripts, we identified the transcription factors Klf4, Klf10 and Atf3, which were previously
uncharacterized within the hypothalamus.
Conclusion: To our knowledge, this is one of the first reports identifying transcripts with a potentially important
role during the development of a specific hypothalamic neuronal phenotype. This genome-scale study forms a
rational foundation for identifying genes that might participate in the development and function of hypothalamic
TRH neurons.
Background
The hypothalamus mediates homeostasis by integrating
various endocrine and autonomic responses. Distinct
nuclei of the hypothalamus regulate sleep, circadian
rhythm, energy homeostasis, sexual behaviors and ther-
mogenesis. Despite extensive studies on the physiological
and clinical aspects of hypothalamic function, the mole-
cular mechanisms defining the identity of the neuronal
subtypes within each hypothalamic nucleus during devel-
opment remain poorly defined.
In the murine hypothalamus, five of the neuroendo-
crine phenotypes [corticotropin-releasing hormone
(CRH), thyrotropin releasing hormone (TRH), somatos-
tatin (SS), growth hormone releasing hormone (GHRH),
and dopamine (DA) neurons] are generated during par-
tially overlapping periods of time, mainly from the prolif-
erative neuroepithelium of the third ventricle [1]. Cells
that produce CRH are generated between embryonic (E)
days 12 and E14, with the peak generation at E13. DA
and SS neurons are generated between E11 and E17,
while the GHRH and TRH neurons are generated
between E11 and E15, with the peak generation at E11
and E13, respectively [2-4].
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neuroendocrine cells coexisting in the same hypothalamic
nucleus produce different neuropeptides (e.g. TRH and
CRH) [5,6]. The distinct neurotransmitter phenotypes do
not differ in time of generation and may appear in
response to individual differentiation programs involving
specific gene networks, as demonstrated for serotoniner-
gic, noradrenergic or dopaminergic phenotypes [7].
The development of the central nervous system (CNS) is
achieved through a delicate balance between cell prolifera-
tion, subsequent cell cycle withdrawal and differentiation
to distinctive neuronal phenotypes. Recent observations
have highlighted that both extracellular cues (growth
factors, extracellular matrix, Notch-Delta signaling,
N-CAMs) and intracellular signals (transcription factors)
play pivotal roles in this process [8,9]. In addition, post-
translational histone and/or DNA enzymatic modifica-
tions, collectively called epigenetic gene regulation, also
govern the process of neurogenesis [10].
In vivo models provide evidence that several transcrip-
tion factors belonging to the basic helix-loop-helix,
homeobox and POU domain families determine the
proper establishment and maturation of various neuronal
phenotypes within the hypothalamic nuclei [11-13]. In
spite of these observations, the inductive signals and
final targets of these transcription factors are poorly
characterized.
Our group has previously demonstrated that the neuro-
trophin brain-derived neurotrophic factor (BDNF)
increases hypothalamic Trh mRNA expression in rat E17
p r i m a r yc u l t u r e s .T h eB D N Fe f f e c ti so n l yo b s e r v e di na
population of TRH neurons that express the catalytic iso-
form of the BDNF receptor, TrkB [14]. In vivo studies
have also demonstrated that the expression of the TrkB
receptor precedes chronologically that of TRH in the
paraventricular nucleus (PV N )o ft h er a th y p o t h a l a m u s ;
the effect of BDNF on Trh mRNA expression can also be
observed in primary cultures of PVN neurons [15].
BDNF likely regulates the acquisition and/or mainte-
nance of this phenotype during development. To gain a
better understanding of the genes that control differen-
tiation of a specific phenotype in the hypothalamic neu-
rons, we performed a genome-wide study to characterize
the transcriptome of hypothalamic TRH neurons during
the terminal phase of differentiation. This represented a
c h a l l e n g es i n c et h eh y p o t h a l a m i cT R Hc e l l sc o n s t i t u t e
only about 2% of the total cell population. To address
this issue, we took advantage of the fact that the -774/
+84 bp regulatory region of the Trh promoter confers tis-
sue specific expression [16] and allows expression of the
green fluorescent protein (GFP) in the TRH expressing
cells. Purification of the TRH cell population was per-
formed by fluorescence activated cell sorting (FACS) as
described previously [17].
In this report, we show that hypothalamic TRH neurons
undergoing the terminal phase of differentiation, expressed
genes implicated in protein biosynthesis, intracellular sig-
naling, and transcriptional regulation. Among the tran-
scripts enriched in the TRH neurons, we identified three
potentially relevant transcription factors: the Krüppel-like
factor 4 (Klf4), the transforming growth factor beta
[TGFß] inducible early growth response factor (Klf10),
also known as Tieg1, and the activating transcription fac-
tor 3 (Atf3). To our knowledge, this is the first report
identifying these transcription factors during hypothalamic
development. Current experiments in our group have
shown that Klf4 and Klf10 regulate Trh gene expression.
W ep r o v i d eam o l e c u l a rt o o l k i tv i aac o m p e n d i u mo f
expression data that can help unravel mechanisms of
hypothalamic TRH neuron development.
Results
Enrichment of embryonic hypothalamic TRH neurons
To obtain information about the transcriptome of devel-
oping TRH expressing cells, we induced GFP expression
in TRH neurons using transfected primary hypothalamic
cultures derived from rat embryos of 17 days of gestation.
This stage corresponds to the terminal phase of differen-
tiation of the TRH phenotype in the hypothalamus [18].
TRH neurons were enriched by FACS. The transcriptome
of the TRH neurons and hypothalamic cells was deter-
mined by DNA microarray technology (Figure 1A).
We have previously reported the conditions to efficiently
transfect TRH neurons in serum-supplemented cultures;
control experiments suggested that most GFP+ cells were
TRH neurons [17]. Taking advantage of these conditions,
we transfected E17 hypothalamic cultures with a GFP
expression vector under the control of the minimal Trh
promoter region (phrTRH-GFP) and determined the
transfection efficiency by FACS. After 48 h of transfection,
0.4% of cells were GFP+ (Figure 1B, middle panel). Pre-
parative cell sorting followed by FACS analysis of the GFP
+ cell population demonstrated a strong enrichment with
approximately 94% of cells being GFP+ (Figure 1B, lower
panel). In general, cell viability was higher than 90% in all
conditions examined as determined by propidium iodide
(PI) staining (data not shown).
To corroborate the neuronal identity of the sorted GFP+
cell population, the expression of Trh together with cell-
type specific markers was examined by RT-PCR assays.
GFP+ cells were separated from the GFP- cells by FACS
48 h after transfection. As a control, a mixed cell popula-
tion consisting of GFP+ and GFP- cells was obtained from
sorted transfected cultures without selection (GFP+/-),
whereas non-transfected cells (NT) (at 3 days in vitro)
were used to establish the basal levels of mRNA expres-
sion. An increase in Trh mRNA levels was observed in the
GFP+ cells compared with NT cells; this was also evident
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Trh expression in the isolated GFP+ cells correlated with
an increase in the expression of the neuronal marker tau,
whereas the expression of the glial cell marker gfap dimin-
ished (Figure 1C). As expected, Gfp mRNA was present
only in the GFP+ and GFP+/- samples (Figure 1C). These
data, together with our previous report [17], indicate that
the sorting conditions permitted the enrichment of TRH
n e u r o n sf r o mam i x e dp r i m a r yc e l lc u l t u r eu s i n gG F P
expression as a marker of Trh proximal promoter activity.
DNA microarray analysis of TRH neurons and
hypothalamic cells
Once we corroborated that TRH cells were enriched in
the GFP+ cell population, total RNA from GFP+ cells
was isolated from a pool of six independent experiments.
Figure 1 Characterization of the TRH/GFP+ cell population in primary cultures of rat fetal hypothalamic cells. A) Strategy to obtain a neuronal
population enriched in TRH cells from primary cultures of fetal (E17) hypothalamic cells. Primary cultures were transfected with a vector driving GFP
expression under the control of the Trh promoter (TRH-GFP; referred as phrTRH-GFP in materials and methods) and GFP+ cells were sorted by flow
cytometry. GFP+ cells were used to generate the target cRNA to hybridize the U34A array. Non-sorted hypothalamic cells and non-transfected cells
were used as control. B) Representative FACS plots indicating the number of GFP+ cells (M1) in a logarithmic scale for 1 × 10
4 events. The upper panel
indicates the distribution of fluorescence in the non-transfected cell population; the middle panel indicates the distribution of fluorescence in cells
transfected with phrTRH-GFP; the percentage of GFP+ cells is indicated on the top. Lower panel: after GFP+ cells were isolated by preparative FACS,
they were submitted to a second pass through the FACS to determine the percentage of GFP+ cells in the enriched population; it rose to 94%. C)
Several marker transcripts were amplified by RT-PCR. The thyrotropin releasing hormone (trh)a n dtau transcripts were used as neuronal markers, the
glial fibrillary acidic protein (gfap) as glial cell marker and the green fluorescent protein (gfp) for transfection control. The glyceraldehyde 3-phosphate
dehydrogenase (g3pdh) was used as a control. D) Analysis of transcripts identified in the GFP+ cell population according to microarray data:
neurofilament heavy polypeptide (nefh), vitamin D3 up-regulated transcript (vdup1), and krüppel-like factor 4 (Klf4); the g3pdh was used as internal
control. GFP+, transfected purified cells; GFP+/-, transfected non-purified cell population; NT, non-transfected cell population.
Guerra-Crespo et al. BMC Genomics 2011, 12:222
http://www.biomedcentral.com/1471-2164/12/222
Page 3 of 13A pool from three other independent experiments was
used to isolate total RNA from GFP+/- and NT cells.
These RNA preparations were used to synthesize biotiny-
lated cRNA targets and to screen U34A DNA
microarrays.
In the array-screening experiment, two separate aliquots
of GFP+ and GFP+/-RNAs, and a single one for NT RNA
were used. Target generated from each aliquot was hybri-
dized to an array, generating single (NT) and replicate
(GFP+ and GFP+/-) datasets. Within the rat U34A oligo-
nucleotide microarray, we distinguished genes based on
whether or not they had a well-characterized gene name
in the GenBank database. 7699 probe sets were known
genes and 1130 probe sets did not have an assigned gene
symbol (expressed sequence tags, ESTs); the total number
of transcripts analyzed was 8829 (see http://www.ncbi.nlm.
nih.gov/geo/ array).
Analysis of the signal intensity with the Microarray Suite
(MAS) 5.0 software (Affymetrix) provides a statistical
mean to determine the presence or absence of a gene in a
sample. This test is based on the comparison of the hybri-
dization efficiency of the target to its complementary
sequence with the cross-hybridization of the target to a
mismatch sequence identical to the complementary
sequence except for one base. Each gene is represented by
16 probe pairs, with one of the members of each pair con-
taining one mismatch, selected from distinct regions of
t h eg e n e .T h es i g n a lv a l u e sf r o mt h e s ep r o b e sw e r eu s e d
to determine the presence of a gene in the target and a P
value calculated from these data. A P value of less than
0.05 was used as a cutoff to consider that a transcript was
present and a P value above this threshold indicated that it
was absent. Transcripts were considered significantly pre-
sent or absent based on the following criteria: a) the nor-
malized value from mean differences was higher than the
microarray background and, b) the fold change between
match and mismatch signals was higher than 2.
On the basis of this analysis, the percentage of transcripts
present in the GFP+ and GFP+/- populations was very
similar. In the GFP+ cell population, 41% (2929 annotated
transcripts and 583 ESTs) of the genes represented on the
microarray were present, whereas 59% (4664 annotated
transcripts and 398 ESTs) were absent (Additional file 1,
Table S1). In the GFP+/- cell population, 41% of the genes
(2941 annotated transcripts and 639 ESTs) were present
and 59% (4756 annotated transcripts and 434 ESTs) were
absent. In the NT cell population, 42% (3014 annotated
transcripts and 571 ESTs) of the genes were present and
58% (4583 annotated transcripts and 410 ESTs) were
absent.
Enriched transcripts in the TRH neurons
To identify the set of enriched transcripts in the GFP+
population, we selected genes with a significant level of
differential expression. This involved first grouping the
two replicates of the control (i.e. GFP+/-) as well as that
of the sorted sample’s (i.e. GFP+) expression data. Signal
intensities of the two replicates of control and sorted
datasets were averaged to represent the expression level
of a transcript in the respective control and sorted
populations. These averaged intensities were used to cal-
c u l a t et h ef o l de n r i c h m e n ti ne x p r e s s i o ni ns o r t e ds a m -
ple over the control for each transcript. A threshold of
more than 2 fold increase or decrease in expression was
considered significant to identify transcripts which are
enriched in one sample but underrepresented in the
other (Table 1).
This analysis revealed that 30 transcripts were
enriched in the GFP+ cells (Table 1). As expected, of
the 30 transcripts enriched, we identified some tran-
scripts previously associated with a neuronal phenotype,
like the neurofilament heavy chain polypeptide (Nefh)
[19], a voltage-dependent calcium channel [20], and a
nicotinic alpha-receptor subunit [21]. Three of the
enriched transcripts corresponded to novel transcripts
within the developing hypothalamus, the Krüppel-like 4
transcription factor (Klf4), the TGFb-inducible early
growth response transcription factor (Klf10), also known
as Tieg1, and the activator of transcription factor 3
(Atf3). In addition, a transcript up-regulated by vitamin
D3 (Vdup1) was enriched in the TRH/GFP+ cell popula-
tion, suggesting a potential physiological role of this
vitamin within the hypothalamic TRH neurons, in
agreement with previously reported data [22].
On the other hand, we found that some of the tran-
scripts diminished in TRH/GFP+ cells (i.e. were probably
not expressed in TRH cells) were associated with the glial
cell phenotype. Among them are the collagen type I and
type III (Col3a) [23,24], and the follistatin-like gene, highly
expressed in astroglial cells [25]. We also identified tran-
scripts associated with cell cycle regulation, like annexin I,
which negatively regulates cyclin D1 gene expression [26]
(Additional file 1, Table S2).
We then decreased the microarray threshold to 1.5 fold
change to determine if any missing classes of genes can
be identified in the different cell populations. We used a
heat map presentation and the gene expression profile to
establish a hierarchical map based on the similarity of the
gene expression values. The first scale, which is asso-
ciated with a coloured strap, refers to genes with up-
regulated (red) or down-regulated (green) expression
levels in each cell population (Figure 2). The second scale
represents the degree of regulation similarity among the
genes. A value of zero indicates that the transcripts have
the same regulation profile. Figure 2 shows part of the
transcripts identified in each cell population. This analy-
sis confirmed the enrichment of various transcripts (Klf4,
Atf3, Nefh) in the GFP+ cells.
Guerra-Crespo et al. BMC Genomics 2011, 12:222
http://www.biomedcentral.com/1471-2164/12/222
Page 4 of 13To validate the microarray data, we performed RT-PCR
analyses for some of the transcripts presumably enriched
in the GFP+ cell population. The levels of mRNAs for
Nefh, Vdup1,a n dKlf4 were increased in the purified
population when compared to the NT or GFP+/- cell
populations (Figure 1D). On the contrary, the glial pheno-
type associated transcripts, Gafp and Col3a, were absent
in the GFP+ cell population (Figure 1C and 1D). These
results confirmed our microarray data.
Transcripts unique to the TRH neurons
To further breakdown the microarray data, a second
method of analysis of the original signal intensities
derived from the MAS software analysis was performed
Table 1 Specific transcripts enriched in the TRH+/GFP+ cell population in a log2-based analysis (P value < 0.05)
Entrez Gene ID Gene Name Gene
symbol
log 2
Cytoskeleton
24587 Neurofilament, heavy polypeptide Nefh 7.04
314856 Transcribed sequence similar to protein Mdm2 Mdm2 3.87
p53 binding protein homolog
Cytoplasmic
288656 Transcribed sequence with similarity to ADP- Arl6ip4 1.03
ribosylation-like factor 6 interacting protein 4
Splicing events
114121 Cyclin L Ccnl1 1.45
Cell signalling
24373 Follistatin Fst 1.37
171347 Methionine adenosyltransferase II, alpha Mat2a 1.12
304268 RAS-like family 11 member a Rasl11a 1.17
17872 Transcribed sequence with similarity to myeloid Myd116 1.44
differentiation primary response gene 116
54305 Somatostatin receptor subtype 2 Sstr2 2.8
Transcription
114505 Kruppel-like factor 4 (gut) Klf4 2.6
25389 Activating transcription factor 3 Atf3 2.05
81813 TGFB inducible early growth response Klf10 1.78
117514 Upregulated by 1,25-dihydroxyvitamin D-3 Txnip 1.32
314322 Rat c-fos mRNA Fos 2.99
Cell cycle
361915 Hypothetical protein LOC361915 ND 1.04
Metabollic
154516 P glucuronosyltransferase 1 family, polypeptide A7C Ugt1a7c 1.05
25617 Glucose-regulated protein GRP78 Hspa5 1.10
Neurotransmission
25302 Nicotinic receptor alpha 7 subunit Chrna7 1.19
641625 Rat genes for vasopressin, oxytocin and a long interspersed repeated ND 1.45
ND Transcribed sequences similar to Cacnb2 and the Nsun6 gene for NOL1/NOP2/Sun domain family 6 ND 1.08
24766 Sodium channel, voltage-gated, type II, alpha 1 polypeptide Scn2a1 2.06
Unknown
AI639457 Not similitude to any gene found ND 2.89
U31866 Not similitude to any gene found ND 1.59
AI639457 Not similitude to any gene found ND 1.59
AI639215 Not similitude to any gene found ND 1.01
M13100 Not similitude to any gene found 1.02
363278 Transcribed sequence simmilar to ATG16 autophagy related 16-like 1 (S. cerevisiae) Atg16l1 1.08
M13100 Unknown protein ND 1.18
M13101 Unknown protein ND 1.29
M13100 Not similitude to any gene found ND 1.16
ND, non determined
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identify transcripts present in the different cell popula-
tions with a high degree of certainty. Using a P value of
< 0.001, we identified a total of 1864 and 1701 tran-
scripts whose presence in the two GFP+/-replicates was
significant. Similarly, we identified 1776 and 1714 tran-
scripts in the replicate samples for the GFP+ cell popu-
lation. In the NT cell population, we identified 1925
transcripts.
In order to identify the transcripts that were present in
both replicates and to reduce the false positive rate in the
detection of expressed transcripts, we defined the repre-
sentative set of each sample as that containing transcripts
significantly expressed in both replicates according to the
P < 0.001 threshold. This resulted in 1600 [of which 288
were ESTs (Additional file 1, Table S4)] transcripts as
representative of the GFP+ cell population (Figure 3 and
Additional file 1, Table S3) and 1630 transcripts for the
GFP+/- cell population. As shown in Figure 3, the over-
lap between the three cell populations indicates that 1361
transcripts were common to the three populations,
whereas 112 transcripts were common to the GFP+ and
GFP+/- cell populations but not expressed in the NT cell
population. This comparison also shows that 51 tran-
scripts were unique to the GFP+/- cell population, while
50 transcripts were unique to the GFP+ cell population
at these thresholds. It should be noted that in this con-
text unique transcripts refer to those transcripts that are
uniquely detected in one or more populations shown in
t h eV e n nd i a g r a m ,a st h e ya r el i k e l yt ob ee x p r e s s e di n
Figure 2 Hierarchical clustering of differently expressed transcripts in hypothalamic cells. The color strap indicates degrees of up- (red)
and down- (green) regulation of gene expression. The dendrogram at the right shows the grouping of genes according to their similarity in
expression profiles. A value of zero indicates that the genes have the same regulation profile. The transfected purified (GFP+) cell population was
compared to the transfected non-purified (GFP+/-) or non-transfected (NT) cell populations in a log2-based threshold. The data correspond to
transcripts enriched in the GFP+ cells only. The gene hierarchical cluster was performed using the multiple group analysis and the CLARA
algorithm as described [54].
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populations. According to their GenBank annotations,
several of these 50 transcripts (unique to GFP+ cells) are
related to neuronal phenotype, e.g. synaptojanin 1
(Synj1); to translation machinery, e.g. eukaryotic transla-
tion initiation factor 3 subunit 9 (Eif3s9), ribosomal pro-
tein L27 (Rpl27); to basal metabolic machinery, e.g. acyl-
CoA synthetase long-chain family member 5 (Acsl5),
solute carrier family 37 member 4 (Slc37a4); to cell sig-
naling, e.g. the serine-threonine kinase 38 (Stk38); in
addition, transcripts encoding proteins with RNA-proces-
sing properties were also observed, i.e. the nuclear tran-
scription factor Y gamma (Nfyc), the splicing factor
arginine/serine-rich 10 (Sfrs10) and the Y box protein 1
(Ybx1). Transcripts related to CNS development were
also identified, i.e. neurofilament heavy chain polypeptide
(Nefh), and the nuclear factor I/B (Nifb). A transcript
with chromatin remodeling properties, the transforma-
tion/transcription domain-associated protein (Trapp)
was also identified (Table 2). These transcripts may play
a critical role in the fetal development of hypothalamic
TRH neurons.
Discussion
Events occurring during development are tightly coupled
to gene expression regulation. Some specific genes have
been related to the establishment of neuronal phenotypes
within the hypothalamic area. Particularly, the transcrip-
tion factors Otp, Sim1, Sim2, as well as Brn2 have impor-
tant roles in hypothalamic architecture (reviewed in
[27,28]). The absence of either of these transcription fac-
tors during embryonic development leads to anatomical
and molecular hypothalamic impairment and conse-
quently, to the complete lack of expression of specific
hypothalamic peptides [11-13]. However, the signalling
pathways regulating the activity of these transcription
factors and their target genes have not been established.
To obtain some insight into the molecular mechanisms
regulating Trh expression and/or TRH neuron growth
during development, we determined elements of the gene
expression profile of fetal hypothalamic cells enriched in
TRH neurons using the DNA microarray technology.
Our approach does not necessarily identify genes relevant
for birth or migration, but should capture genes impor-
tant for late developmental events involving TRH neuron
specification and function. Here, we report that FACS
enriched TRH neurons, previously cultured for 3 DIV,
can be successfully used to characterize elements of their
transcriptome. The database generated from this analysis
allowed us to identify some transcripts, including several
transcription factors, as novel candidates to regulate
hypothalamic Trh gene expression or TRH neuron
growth during the terminal phase of development.
Among the transcripts enriched in the GFP+ cells, we
identified three transcription factors whose expression
has not been previously reported within the hypothala-
mus in vivo. These transcripts include the zinc finger
domain-containing transcription factor Klf4 [29-32], the
TGFb-inducible early growth response transcription fac-
tor (Klf10) [33,34], and the activating transcription factor
3( Atf3) [35]; these are important regulators of cell differ-
entiation and proliferation in different systems. Recently,
these transcription factors have been identified as NGF-
responsive immediate early genes during PC12 cell differ-
entiation [36].
Experiments performed in our group have corrobo-
rated the relevance of Klf4 for Trh gene expression. Klf4
mRNA is expressed in the embryonic rat hypothalamus,
coincident with the establishment of the TRH phenotype;
in the neonatal rat hypothalamus, Klf4 is expressed in the
PVN, the source of hypophysiotropic TRH. Klf4 binds to
the Trh promoter either in vitro or in vivo during fetal
hypothalamic development. In addition, Klf4 regulates
hypothalamic Trh promoter activity both in vitro and in
vivo during development. Accordingly, Trh expression is
down-regulated at E15 in the hypothalamus of Klf4 defi-
cient mice, resulting in diminished bioactive peptide
level. These data demonstrate that Klf4 is a key molecule
within the differentiation program of the hypothalamic
TRH phenotype [37].
Figure 3 Venn diagram showing the number of transcripts
identified present in each cell population. The circles represent a
specific cell population with the numbers representing the genes
present in each sample (P < 0.001). Numbers in the outer portion of
each circle are specific to that sample. The number in the
innermost portion of the diagram represents transcripts expressed
in the three populations (1361). Likewise, the numbers in the
portions of the diagram shared by two circles represent genes
expressed in those samples but not in the exclusive sample.
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Page 7 of 13Table 2 Unique transcripts identified in the TRH+/GFP+ cell population using a rigorous threshold of P <0
Gene ID Gene Name Gene symbol
S49760_g_at 140866 ND
H31982_at ND ND
AA849648_at ND ND
X83747 ND ND
AA800750 ND ND
AA891631 ND ND
AI104567 Actin alpha cardiac 1 Actc1
AA892318 ADP-ribosylation factor-like 6 interacting protein 4 Arl6ip4
AA892821 Aldo-keto reductase family 7, member A2
(aflatoxin aldehyde reductase)
Akr7a2
AI639209 Ariadne homolog 2 (Drosophila) (predicted) Arih2_predicted
AI103671 ATPase, Ca++ transporting, plasma membrane 1 Atp2b1
M60921 B-cell translocation gene 2, anti-proliferative Btg2
AA892271 BCL2-like 13 (apoptosis facilitator) (predicted) Bcl2l13_predicted
AI639371 Calponin 3, acidic Cnn3
U66471 Cell growth regulator with ring finger domain 1 Cgrrf1
L23148 chr1:175179191-175179595 (+) Y box protein 1
M13101 C-reactive protein, pentraxin-related Crp
AI180350 CTD-binding SR-like protein rA9 LOC245925
X62160 Dynactin 1 Dctn1
AA87520 Eukaryotic translation initiation factor 3, subunit 9 (eta) Eif3s9
AA858520 Follistatin Fst
AI639457 GTP cyclohydrolase 1 Gch
AA799888 Mitochondrial ribosomal protein L40 Mrpl40
X62950 MRNA (pBUS30) with repetitive elements —
AA875126 Myosin IG Myo1g
AA818677 Neurofilament, heavy polypeptide Nefh
AA859994 Nuclear factor I/B Nfib
U17254 Nuclear receptor subfamily 4, group A, member 1 Nr4a1
AA875121 Nuclear transcription factor-Y gamma Nfyc
AF040954 Protein phosphatase 1, regulatory subunit 10 Ppp1r10
AI070277 Proteolipid protein Plp
AA875620 RGD1566118 (predicted) —
AI176589 Ribosomal protein L27 LOC680960 Rpl27
M31018 RT1 class Ib, locus Aw2 RT1-Aw2
M10094 RT1 class Ib, locus Aw2 RT1-Aw2
AI639167 Sequestosome 1 Sqstm1
X05472 Serine incorporator 1///hypothetical protein LOC498354 LOC498354
Serinc1
AA800712 Serine/threonine kinase 38 Stk38
AF080468 Solute carrier family 37 (glycerol-6-phosphate transporter), member 4 Slc37a4
AI639294 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 (predicted) Spock2_predicted
AA955859 Splicing factor, arginine/serine-rich 10 (transformer 2 homolog, Drosophila) Sfrs10
U45479 Synaptojanin 1 Synj1
AI014169 Thioredoxin interacting protein Txnip
AA893320 Transcribed locus (Mus musculus ubiquitin specific peptidase 7 (Usp7). Mus musculus 10 days neonate cerebellum
cDNA
Usp7
AA800693 Transcribed locus, strongly similar to XP_579966.1 hypothetical protein XP_579966 [Rattus norvegicus] (Mus
musculus pyridoxal (pyridoxine, vitamin B6) kinase)
—
AA800513 Transformation/transcription domain-associated protein (predicted) Trrap_predicted
AI639488 Transformed mouse 3T3 cell double minute 2 homolog (mouse) (predicted) Mdm2_predicted
M92074 Troponin I type 3 (cardiac) Tnni3
AI639320 V-raf murine sarcoma 3611 viral oncogene homolog Araf
AA894321 WD repeat and FYVE domain containing 1 Wdfy1
ND, non determined
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the Krüppel-like family of transcription factors, Klf10.
Experimental evidences show that Klf10 is a positive
regulator of Trh promoter activity in primary cultures of
fetal hypothalamic cells and that its expression coincides
with the establishment of the hypothalamic TRH neu-
rons in vivo [38]. Klf10 binds to the Trh promoter in
vivo during hypothalamus development (Martínez-
Armenta M. et al. unpublished).
Previous reports have demonstrated that Klf4, Klf10
and Atf3 expression is regulated by TGFb [39-41]. Since
TGFb isoforms and their receptors are expressed in the
hypothalamus [42], we have analyzed the effect of this
cytokine in primary hypothalamic cultures. TGFb-2
increased Trh mRNA expression by regulating Trh pro-
moter activity [38]. Furthermore, TGFb-2 induced Klf10
mRNA in primary hypothalamic cultures similarly to
Trh mRNA. Finally, Klf10 was bound to the rat Trh pro-
moter in response to TGFb in vitro (Martínez-Armenta
M. et al. unpublished). Therefore, another of the tran-
scription factors identified in the microarray screening
appears critical for Trh expression.
In this study, we used independent preparations of GFP
+ cells that were pooled to identify transcripts enriched
in TRH neurons. Using independent preparations of GFP
+ cells not only decreases the false positives that are pos-
sibly identified if only one preparation is used but also
enriches the relative concentration of the TRH neuron
specific transcripts compared to the background sample.
Experimental designs using pooling samples are often
performed to reduce the effects of biological variation,
making substantive differences easier to find. Conse-
quently, pooling samples has been used in many gen-
ome-wide-based studies to provide an accurate and
r e l i a b l ee s t i m a t eo fs p e c i f i cg e n ee x p r e s s i o np a t t e r n s ,
DNA methylation profiling, identifying biomarkers, etc.
in a specific cell population [43]. Whether all the tran-
scripts identified in this study are truly enriched in TRH
hypothalamic neurons in vivo,a n dw h e t h e rt h e ya r e
expressed into functional proteins, is not yet known,
except for the evidence mentioned above for two tran-
scripts. Under our experimental conditions, TRH neu-
rons passed through a stage of differentiation in vitro;
thus, the procedure used in the present study might have
altered some aspects of the expression profile of the neu-
rons, leading to some false positives. However, the results
obtained with Klf4 and Klf10 (see previous paragraphs)
suggest that our data should be a useful guide to study
TRH neuron differentiation. However, since TRH neu-
rons are localized in various hypothalamic nuclei [44],
each identified transcript may be either enriched in a spe-
cific TRH neuron type, or in multiple types.
Previous studies have indicated that each neuronal
phenotype possesses a specific differentiation program,
in which in addition to transcription factors [7], epige-
netic modifications and non-coding RNA expression
play pivotal roles. The analysis of the transcriptome of
hypothalamic TRH neurons allowed us to derive experi-
mental data that indicate that Klf4 and Klf10 are impor-
tant regulators of Trh gene expression during the
hypothalamus development. Co-activators, such as the
histone acetyltransferases (p300 and CBP), or co-repres-
sors, such as histone deacetylases (mSin3a), can regulate
Klf4 and Klf10 transcriptional activity [45]. Therefore,
we propose that during hypothalamic development Trh
gene expression is regulated by extracellular signals (i.e.
TGFb, BDNF) that modulate the accessibility of specific
transcription factors (e.g. Klf4 and Klf10) to Trh gene
promoter by local histone modifications. To gain further
insight into the molecular mechanism regulating
hypothalamic neuronal phenotype differentiation, it will
be critical to determine the impact of specific epigenetic
modifications during hypothalamus development.
Conclusions
Although the functional importance of the hypothalamus
has been demonstrated throughout vertebrates, the mole-
cular mechanisms controlling neurogenesis in this fore-
brain structure are poorly understood. The hypothalamic
TRH peptide has multiple hormonal and autonomous
functions. Previous studies have evidenced that pituitary
response to TRH is blunted in a number of psychiatric
conditions, including schizophrenia, bipolar disorders, alco-
holism and depression [46]. Whether specific abnormalities
during the differentiation of hypothalamic TRH neurons
are associated with such disorders remains unknown.
Therefore, knowledge of transcriptional regulation during
the course of TRH neuron differentiation might contribute
to a better understanding of the molecular mechanisms
underlying TRH mediated homeostasis in the adult organ-
ism. For this purpose, we performed a genome wide study
of hypothalamic TRH neurons during late fetal develop-
ment. We report novel transcripts within the hypothala-
mus that may be part of the differentiation program of the
TRH neuronal phenotype. These included the transcription
factors Klf4, Klf10 and Atf3. Although the role of transcrip-
tion factors during neuronal differentiation is well
accepted, we are only at the brink of understanding how
epigenetic mechanisms influence transcriptional activity
and the accessibility of transcription factors to bind to cis-
elements. The identification of transcripts enriched in fetal
hypothalamic TRH neurons will guide further studies on
the differentiation of this phenotype.
Methods
Animals
Wistar rats raised at our animal facility, maintained in
standard environmental conditions (lights on between
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Page 9 of 130700-1900 h, temperature 21 ± 2°C) with rat chow and
tap water ad libitum. Animal care and protocols fol-
lowed the guidelines for the use of animals in neu-
roscience research of the Society for Neuroscience,
USA, and were approved by the Animal Care and Ethics
Committee of the Instituto de Biotecnología, UNAM.
Cell culture and transfection
Hypothalamic primary cultures were prepared from E17
rat embryos as previously described [17]. Briefly, pregnant
Wistar rats were anesthetized with pentobarbital (33 mg/
kg b.w.) and the embryos removed individually. The
hypothalamus was then excised through an imaginary line
between both eye and ear superior edge; the dissected area
was limited by the optic chiasm and lateral sulcus includ-
ing mammillary bodies to a 2-3 mm depth avoiding thala-
mic area. Hypothalami were dissociated with trypsin
(Sigma) and viability monitored by trypan blue exclusion
(95%). Cells (5 × 10
6)w e r ep l a t e do n t op o l y - D - l y s i n e
(Sigma; 10 μg / m l )p r e - c o a t e d6 0m mP e t r id i s h e si n
DMEM supplemented with 10% fetal bovine serum (FBS,
GIBCO), 0.25% glucose (Sigma), 2 mM glutamine (Sigma),
3.3 mg/ml insulin (Sigma), 1% antibiotic-antimycotic
(GIBCO) and 1% vitamin solution (GIBCO). Cultures
were maintained in a REVCO incubator at 37°C in humi-
dified air/7% CO2.
Twenty-four hours after seeding, cells were transfected
essentially as described [17]. In general, 8 mg of branched
polyethylenimine (PEI) (600-1000 KDa; Fluka) solution
was diluted in 10 ml of water, pH adjusted to 6.9 with 0.2
N HCl and the solution filtered (Millipore, 0.22 μm). PEI
(30 μl) and plasmid DNA (10 μg) were separately diluted
to adjust NaCl to 150 mM in a final volume of 50 μl, vor-
texed and incubated for 10 min at room temperature;
subsequently, the polymer solution was added to the
DNA, vortexed-mixed, incubated for 10 min at room
temperature followed by the addition of 900 μlo fs e r u m -
free DMEM. The supplemented DMEM was removed
from the culture dishes and the transfection mixture was
added. After 3 hours incubation, transfection mix was
removed and fresh supplemented DMEM was added.
Forty-eight hours after transfection, cells were trypsinized
(0.25% trypsin-EDTA) and subjected to FACS.
Plasmid construct
The minimal Trh promoter (-776/+84 bp) conferring
tissue-specific expression [16] was excised with EcoR1
and BamH1/EcoRV digestion from the pNASS-rTRH-
Luc expression vector. The Trh promoter fragment
sticky ends were filled with Klenow DNA polymerase
and subsequently sub-cloned into the SacI/BamH1 sites
present on the pACT2 vector. Finally, the Trh promoter
fragment was cloned into the SacI/BamHI sites in the
phrGFP promoterless expression vector (Stratagene) and
sequenced using primers corresponding to the Trh pro-
moter 3’ region (5’-ATG CAT AGA TCT TCT AGA
TA-3’)a n dt ot h ep h r G F P5 ’region (3’-TGC AGG CCG
GTG TTC TTC AGG A-5’); the resulting plasmid was
named phrTRH-GFP.
Fluorescence-activated cell sorting
For preparative cell sorting, 5 × 10
6 hypothalamic cells
plated on 60-mm dishes were transfected as described
above. After 48 h, cells were trypsinized, washed, resus-
pended in PBS/1% FBS (10
7 cells/ml) and filtered through
a4 0μm nylon mesh (BD Bioscience, San Jose, USA).
Cells were purified from a pool of five 60-mm dishes
using the FACS Vantage (Becton Dickinson, San Jose,
CA) and the exclusion method at high speed (60 μl/min).
C e l l sw e r es o r t e du s i n gt h es e t t i n g sp r e v i o u s l yd e s c r i b e d
[17] and analyzed by analytical flow cytometry as
described below. In general, 20,000 GFP+ cells were puri-
fied from 5 × 10
6 cells.
The percentage of GFP+ cells before and after purifica-
tion by preparative cell sorting was determined by analy-
tical flow cytometry using the FACS Vantage. All data
acquisition and analyses were performed using the Cell
Quest software (Becton Dickinson). To estimate the
number of GFP+ cells, a FL1 histogram was generated
(FL1, 530/30 nm short pass filter, detects green signal)
and positive cells were defined as those cells in the region
M1. The percentage of cells in M1 from the empty vector
(mock)-transfected cells was subtracted from the percen-
tage of plasmid-transfected cells in M1. Cell viability was
determined using propidium iodide (PI) (Sigma) as
reported [47]. PI fluorescence was detected with the FL2
emission channel (585/42 nm band pass filter). The per-
centage of dead cells was determined as the percentage
of PI+ cells in a FL1 versus FL2 plot after subtracting the
percentage of PI+ cells from the mock-transfected cells.
DNA microarray analysis
The microarray analysis was performed as described in
the Affymetrix expression analysis technical manual
http://www.affymetrix.com. Total RNA (10 μg) was
extracted from three different cell populations: i) sorted
TRH-GFP+ cells (GFP+); ii) TRH-GFP+ and GFP- mixed
cells (GFP+/-) passed through the FACS but not sorted,
and iii) non-transfected cells (NT). To obtain a sufficient
amount of RNA for each cell population, the number of
independent experiments pooled for the GFP+ sample
was higher than for the other samples. Therefore, a pool
of six independent experiments was used to prepare total
RNA from the GFP+ and three independent experiments
for GFP+/- or NT cells.
The microarray target was synthesized from total
RNA. RNA was reverse-transcribed into double-stranded
cDNA with a T7 promoter-containing primer using
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Page 10 of 13SuperScript II reverse transcriptase, RNase H, and DNA
polymerase (Invitrogen). After precipitation with 5M
NH4OAc and ethanol, the cDNA was used as a template
in a biotin-labeled in vitro transcription reaction (Enzo
BioArray, Affymetrix). Resulting target cRNA was col-
lected on RNAeasy columns (QIAGEN, Valencia, CA)
a n dt h e nf r a g m e n t e df o rh y b r i d i z a t i o no nt h e
microarrays.
The rat U34A microarray from Affymetrix was used. It
contains probes for approximately 7699 well-annotated
genes and around 1130 expressed sequence tags (ESTs)
from Rattus norvegicus. Probes consist of 16 pairs of 25-
mer oligonucleotides for each gene. One member of each
pair contains a single base point mutation, and the sig-
nals of the pairs are compared to assess specificity of
hybridization. Biotinylated target cRNA (15 μg) was
hybridized to the array and then processed using the
Affymetrix GeneChip Fluidics Workstation 400. After
binding with phycoerythrin-coupled avidin, microarrays
were scanned on a Hewlett-Packard Gene Array Scanner
(Hewlett-Packard Co., Palo Alto, CA). Data were depos-
ited in the NCBI Gene Expression Omnibus repository
http://www.ncbi.nlm.nih.gov/geo/ with the accession
number GSE28441.
Results were analyzed using Affymetrix MAS 5.0 soft-
ware. Individual microarrays were scaled to produce a
mean signal intensity of 125. Iterative comparisons of dif-
ferent microarray datasets were done with MAS 5.0 com-
parison analysis as previously described with modifications
[48]. To determine the expression difference between the
GFP+ and GFP+/- cell populations, an additional
approach was adopted. This involved grouping the two
replicates of the control (i.e, GFP+/-) and the sorted sam-
ple (i.e, GFP+). Briefly, signal intensities of the two repli-
cates of control and sorted datasets were averaged to
represent the expression level of a transcript in the respec-
tive control and sorted populations. These averaged inten-
sities were then used to calculate the fold enrichment in
expression in sorted sample over control for each tran-
script. To identify transcripts that are enriched in one
sample but underrepresented in the other, a threshold of
more than 2 fold increase or decrease in expression was
considered significant.
RT-PCR
RNA was extracted as previously described [18]. Reverse
transcription (RT) was performed with 1 μgo fR N A
using the M-MLV reverse transcriptase (Invitrogen) in
t h ep r e s e n c eo fo l i g o - d T 15 primer. PCR was carried out
in a total reaction volume of 50 μl. Primers (Additional
file 1, Table S5) were designed using the PRIMER 3
software [49]. In general, PCRs were performed using 25
pmol of each of the specific forward and reverse
primers, 1 μl of dNTP mix (20 mM each; Boehringer)
and 1/5 of the RT reaction product.
Transcripts amplified by PCR included: Krüppel-like
factor 4, collagen type III alpha 1 (Gene ID 84032), up-
regulated by 1,25 dihydroxyvitamin D-3 (Gene ID
117514), neurofilament heavy chain [50], green fluores-
cent protein [51], Trh, glyceraldehyde 3-phosphate dehy-
drogenase (g3pdh) [18], Tau [52] and the glial fibrillary
acidic protein [53]. Amplification was performed for 30
cycles except for g3pdh (24 cycles). PCR cycling condi-
tions consisted of one cycle of melt temperature of 94°C
f o r1m i n ,ap r i m e ra n n e a l i n gs t e pa t6 0 ° Co r6 4 ° C
(Klf4) for 1 min, a polymerization step at 72°C for 1
min and a final extension at 72°C for 10 min. PCR pro-
ducts were electrophoresed in 2% agarose gel and bands
stained with ethidium bromide.
Acknowledgements
We thank Affymetrix for the microarray processing and data analysis. We
also thank Dr. Jeffrey Bond from the Bioinformatics Core facility at the
University of Vermont for the bioinformatics analysis. We are grateful to Dr.
Gustavo Pedraza-Alva for insightful scientific discussions, to M. Cisneros, M.
Villa and E. Martel for technical support. We also thank S. González for
maintaining our rat colony. This work was supported by grants from
DGAPA-UNAM (IN227506-3, IN224909) and CONACYT (61208, 42605).
Author details
1Departamento de Genética y Fisiología Molecular, Instituto de
Biotecnología, Universidad Nacional Autónoma de México (UNAM),
Cuernavaca, Morelos, México.
2Laboratory of Molecular Biology, Medical
Research Council, Hills Road, Cambridge CB2 0QH, UK.
3Centro de Ciencias
Genómicas, Universidad Nacional Autónoma de México (UNAM), Cuernavaca,
Morelos, México.
4Departamento de Microbiología Molecular, Instituto de
Biotecnología, Universidad Nacional Autónoma de México (UNAM),
Cuernavaca, Morelos, México.
5Departamento de Medicina Molecular y
Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de
México (UNAM), Cuernavaca, Morelos, México.
6Institute for Genomic
Biology, University of Illinois at Urbana-Champaign, Urbana, 61801, USA.
Authors’ contributions
MG-C carried out primary cultures and transfection experiments, FACS,
prepared the RNA for pooling and validation by RT-PCR, CP-M assisted with
the data analysis and participated in writing the manuscript, SCJ performed
the majority of the data analysis, SC-R assisted with the data analysis, RMG-R
assisted with some data analysis and PJ-B participated in the design of the
study, LP-M and J-LC conceived the study, participated in the design and
coordination of the study and wrote the manuscript. All authors read and
approved the final manuscript.
Received: 13 January 2010 Accepted: 10 May 2011
Published: 10 May 2011
References
1. Markakis EA: Development of the neuroendocrine hypothalamus. Front
Neuroendocrinol 2002, 23:257-291.
2. Markakis EA, Swanson LW: Spatiotemporal patterns of secretomotor
neuron generation in the parvicellular neuroendocrine system. Brain Res
Brain Res Rev 1997, 24:255-291.
3. Angevine JB Jr: Time of neuron origin in the diencephalon of the mouse.
An autoradiographic study. J Comp Neurol 1970, 139:129-187.
4. Karim MA, Sloper JC: Histogenesis of the supraoptic and paraventricular
neurosecretory cells of the mouse hypothalamus. J Anat 1980,
130:341-347.
Guerra-Crespo et al. BMC Genomics 2011, 12:222
http://www.biomedcentral.com/1471-2164/12/222
Page 11 of 135. Sawchenko PE, Imaki T, Vale W: Co-localization of neuroactive substances
in the endocrine hypothalamus. Ciba Found Symp 1992, 168:16-30,
discussion 30-42.
6. Ludwig M, Leng G: Dendritic peptide release and peptide-dependent
behaviours. Nat Rev Neurosci 2006, 7:126-136.
7. Goridis C, Rohrer H: Specification of catecholaminergic and serotonergic
neurons. Nat Rev Neurosci 2002, 3:531-541.
8. Edlund T, Jessell TM: Progression from extrinsic to intrinsic signaling in
cell fate specification: a view from the nervous system. Cell 1999,
96:211-224.
9. Perez-Martinez L, Jaworski DM: Tissue inhibitor of metalloproteinase-2
promotes neuronal differentiation by acting as an anti-mitogenic signal.
J Neurosci 2005, 25:4917-4929.
10. Hsieh J, Gage FH: Chromatin remodeling in neural development and
plasticity. Curr Opin Cell Biol 2005, 17:664-671.
11. Schonemann MD, Ryan AK, McEvilly RJ, O’Connell SM, Arias CA, Kalla KA,
Li P, Sawchenko PE, Rosenfeld MG: Development and survival of the
endocrine hypothalamus and posterior pituitary gland requires the
neuronal POU domain factor Brn-2. Genes Dev 1995, 9:3122-3135.
12. Hosoya T, Oda Y, Takahashi S, Morita M, Kawauchi S, Ema M, Yamamoto M,
Fujii-Kuriyama Y: Defective development of secretory neurones in the
hypothalamus of Arnt2-knockout mice. Genes Cells 2001, 6:361-374.
13. Michaud JL, DeRossi C, May NR, Holdener BC, Fan CM: ARNT2 acts as the
dimerization partner of SIM1 for the development of the hypothalamus.
Mech Dev 2000, 90:253-261.
14. Guerra-Crespo M, Ubieta R, Joseph-Bravo P, Charli JL, Perez-Martinez L:
BDNF increases the early expression of TRH mRNA in fetal TrkB+
hypothalamic neurons in primary culture. Eur J Neurosci 2001, 14:483-494.
15. Ubieta R, Uribe RM, Gonzalez JA, Garcia-Vazquez A, Perez-Monter C, Perez-
Martinez L, Joseph-Bravo P, Charli JL: BDNF up-regulates pre-pro-TRH
mRNA expression in the fetal/neonatal paraventricular nucleus of the
hypothalamus. Properties of the transduction pathway. Brain Res 2007,
1174:28-38.
16. Balkan W, Tavianini MA, Gkonos PJ, Roos BA: Expression of rat thyrotropin
releasing hormone (TRH) gene in TRH-producing tissues of transgenic
mice requires sequences located in exon 1. Endocrinology 1998,
139:252-259.
17. Guerra-Crespo M, Charli JL, Rosales-Garcia VH, Pedraza-Alva G, Perez-
Martinez L: Polyethylenimine improves the transfection efficiency of
primary cultures of post-mitotic rat fetal hypothalamic neurons. J
Neurosci Methods 2003, 127:179-192.
18. Perez-Martinez L, Charli JL, Joseph-Bravo P: Development of pro-TRH gene
expression in primary cultures of fetal hypothalamic cells. Brain Res Dev
Brain Res 2001, 130:73-81.
19. Thyagarajan A, Strong MJ, Szaro BG: Post-transcriptional control of
neurofilaments in development and disease. Exp Cell Res 2007,
313:2088-2097.
20. Ross WN, Nakamura T, Watanabe S, Larkum M, Lasser-Ross N: Synaptically
activated ca2+ release from internal stores in CNS neurons. Cell Mol
Neurobiol 2005, 25:283-295.
21. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW: Mammalian nicotinic
acetylcholine receptors: from structure to function. Physiol Rev 2009,
89:73-120.
22. Tornquist K, Lamberg-Allardt C: Systemic effects of 1,25-dihydroxyvitamin
D3 on the pituitary-hypothalamic axis in rats. Acta Endocrinol (Copenh)
1987, 115:225-228.
23. Bunge MB, Williams AK, Wood PM, Uitto J, Jeffrey JJ: Comparison of nerve
cell and nerve cell plus Schwann cell cultures, with particular emphasis
on basal lamina and collagen formation. J Cell Biol 1980, 84:184-202.
24. Greenberg JH, Foidart JM, Greene RM: Collagen synthesis in cultures of
differentiating neural crest cells. Cell Differ 1980, 9:153-163.
25. Zhang G, Ohsawa Y, Kametaka S, Shibata M, Waguri S, Uchiyama Y:
Regulation of FLRG expression in rat primary astroglial cells and injured
brain tissue by transforming growth factor-beta 1 (TGF-beta 1). J
Neurosci Res 2003, 72:33-45.
26. Alldridge LC, Bryant CE: Annexin 1 regulates cell proliferation by
disruption of cell morphology and inhibition of cyclin D1 expression
through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res
2003, 290:93-107.
27. Michaud JL: The developmental program of the hypothalamus and its
disorders. Clin Genet 2001, 60:255-263.
28. Burbach JP, Luckman SM, Murphy D, Gainer H: Gene regulation in the
magnocellular hypothalamo-neurohypophysial system. Physiol Rev 2001,
81:1197-1267.
29. Shields JM, Christy RJ, Yang VW: Identification and characterization of a
gene encoding a gut-enriched Kruppel-like factor expressed during
growth arrest. J Biol Chem 1996, 271:20009-20017.
30. Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B: A gene
for a novel zinc-finger protein expressed in differentiated epithelial cells
and transiently in certain mesenchymal cells. J Biol Chem 1996,
271:31384-31390.
31. Panigada M, Porcellini S, Sutti F, Doneda L, Pozzoli O, Consalez GG,
Guttinger M, Grassi F: GKLF in thymus epithelium as a developmentally
regulated element of thymocyte-stroma cross-talk. Mech Dev 1999,
81:103-113.
32. Segre J: Complex redundancy to build a simple epidermal permeability
barrier. Curr Opin Cell Biol 2003, 15:776-782.
33. Bieker JJ: Kruppel-like factors: three fingers in many pies. J Biol Chem
2001, 276:34355-34358.
34. Cook T, Gebelein B, Belal M, Mesa K, Urrutia R: Three conserved
transcriptional repressor domains are a defining feature of the TIEG
subfamily of Sp1-like zinc finger proteins. J Biol Chem 1999,
274:29500-29504.
35. Xie J, Roberson MS: 3’,5 ’-cyclic adenosine 5’-monophosphate response
element-dependent transcriptional regulation of the secretogranin II
gene promoter depends on gonadotropin-releasing hormone-induced
mitogen-activated protein kinase activation and the transactivator
activating transcription factor 3. Endocrinology 2008, 149:783-792.
36. Dijkmans TF, van Hooijdonk LW, Schouten TG, Kamphorst JT, Fitzsimons CP,
Vreugdenhil E: Identification of new Nerve Growth Factor-responsive
immediate-early genes. Brain Res 2009, 1249:19-33.
37. Perez-Monter C, Martinez-Armenta M, Miquelajauregui A, Furlan-Magaril M,
Varela-Echavarria A, Recillas-Targa F, May V, Charli JL, Perez-Martinez L: The
Kruppel-like factor 4 controls biosynthesis of thyrotropin releasing
hormone during hypothalamus development. Mol Cell Endocrinol
333:127-133.
38. Martinez-Armenta M, Charli J-L, Perez-Martinez L: The role of Klf10 during
differentiation of hypothalamic TRH neurons. 39th annual meeting of the
Society for Neuroscience (SfN) October 17-21; Chicago, IL 2009.
39. King KE, Iyemere VP, Weissberg PL, Shanahan CM: Kruppel-like factor 4
(KLF4/GKLF) is a target of bone morphogenetic proteins and
transforming growth factor beta 1 in the regulation of vascular smooth
muscle cell phenotype. J Biol Chem 2003, 278:11661-11669.
40. Hefferan TE, Subramaniam M, Khosla S, Riggs BL, Spelsberg TC: Cytokine-
specific induction of the TGF-beta inducible early gene (TIEG): regulation
by specific members of the TGF-beta family. J Cell Biochem 2000,
78:380-390.
41. Kang Y, Chen CR, Massague J: A self-enabling TGFbeta response coupled
to stress signaling: Smad engages stress response factor ATF3 for Id1
repression in epithelial cells. Mol Cell 2003, 11:915-926.
42. Bouret S, De Seranno S, Beauvillain JC, Prevot V: Transforming growth
factor beta1 may directly influence gonadotropin-releasing hormone
gene expression in the rat hypothalamus. Endocrinology 2004,
145:1794-1801.
43. Rampon C, Jiang CH, Dong H, Tang YP, Lockhart DJ, Schultz PG, Tsien JZ,
Hu Y: Effects of environmental enrichment on gene expression in the
brain. Proc Natl Acad Sci USA 2000, 97:12880-12884.
44. Segerson TP, Hoefler H, Childers H, Wolfe HJ, Wu P, Jackson IM, Lechan RM:
Localization of thyrotropin releasing hormone prohormone messenger
ribonucleic acid in rat brain in situ hybridization. Endocrinology 1987,
121:98-107.
45. Evans PM, Zhang W, Chen X, Yang J, Bhakat KK, Liu C: Kruppel-like factor 4
is acetylated by p300 and regulates gene transcription via modulation
of histone acetylation. J Biol Chem 2007, 282:33994-34002.
46. Gary KA, Sevarino KA, Yarbrough GG, Prange AJ Jr, Winokur A: The
thyrotropin releasing hormone (TRH) hypothesis of homeostatic
regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther
2003, 305:410-416.
47. Boldyrev A, Song R, Lawrence D, Carpenter DO: Carnosine protects against
excitotoxic cell death independently of effects on reactive oxygen
species. Neuroscience 1999, 94:571-577.
Guerra-Crespo et al. BMC Genomics 2011, 12:222
http://www.biomedcentral.com/1471-2164/12/222
Page 12 of 1348. Chen YW, Zhao P, Borup R, Hoffman EP: Expression profiling in the
muscular dystrophies: identification of novel aspects of molecular
pathophysiology. J Cell Biol 2000, 151:1321-1336.
49. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for
biologist programmers. Methods Mol Biol 2000, 132:365-386.
50. Sotelo-Silveira JR, Calliari A, Kun A, Benech JC, Sanguinetti C, Chalar C,
Sotelo JR: Neurofilament mRNAs are present and translated in the
normal and severed sciatic nerve. J Neurosci Res 2000, 62:65-74.
51. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC: Green fluorescent
protein as a marker for gene expression. Science 1994, 263:802-805.
52. Sadot E, Marx R, Barg J, Behar L, Ginzburg I: Complete sequence of 3’-
untranslated region of Tau from rat central nervous system. Implications
for mRNA heterogeneity. J Mol Biol 1994, 241:325-331.
53. Hoshimaru M, Ray J, Sah DW, Gage FH: Differentiation of the
immortalized adult neuronal progenitor cell line HC2S2 into neurons by
regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA
1996, 93:1518-1523.
54. Dudoit S, Fridlyand J: A prediction-based resampling method for
estimating the number of clusters in a dataset. Genome Biol 2002, 3:
RESEARCH0036.
doi:10.1186/1471-2164-12-222
Cite this article as: Guerra-Crespo et al.: Transcriptional profiling of fetal
hypothalamic TRH neurons. BMC Genomics 2011 12:222.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Guerra-Crespo et al. BMC Genomics 2011, 12:222
http://www.biomedcentral.com/1471-2164/12/222
Page 13 of 13